3920 related articles for article (PubMed ID: 309867)
1. Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS).
Vánky F; Klein E; Stjernswärd J; Rodriguez L; Péterffy A; Steiner L; Nilsonne U
Int J Cancer; 1978 Dec; 22(6):679-86. PubMed ID: 309867
[TBL] [Abstract][Full Text] [Related]
2. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
Vánky F; Klein E
Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
[TBL] [Abstract][Full Text] [Related]
3. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
4. DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cells.
Vánky F; Klein E; Willems J
Cancer Immunol Immunother; 1985; 19(3):219-25. PubMed ID: 3873987
[TBL] [Abstract][Full Text] [Related]
5. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Uchida A; Moore M; Klein E
Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
[TBL] [Abstract][Full Text] [Related]
6. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors.
Vánky F; Klein E; Stjernswärd J; Trempe G
Int J Cancer; 1975 Nov; 16(5):850-60. PubMed ID: 1058840
[TBL] [Abstract][Full Text] [Related]
8. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.
Palacios R; Llorente L; Alarcón-Segovia D; Ruíz-Arguelles A; Díaz-Jouanen E
J Clin Invest; 1980 Jun; 65(6):1527-30. PubMed ID: 6447710
[TBL] [Abstract][Full Text] [Related]
9. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
10. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.
Vánky F; Péterffy A; Böök K; Willems J; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):17-22. PubMed ID: 6605800
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
Anderson RJ; McBride CM; Hersh EM
Cancer Res; 1972 May; 32(5):988-92. PubMed ID: 4336032
[No Abstract] [Full Text] [Related]
12. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity.
Han T; Takita H
Cancer; 1979 Dec; 44(6):2090-8. PubMed ID: 228835
[No Abstract] [Full Text] [Related]
13. Search for anti-tumor response in a bone tumor patient with a long clinical history.
Vanky F; Klein E; Cornain S; Bakács T; Stjernswärd J; Nilsonne U
Int J Cancer; 1976 Sep; 18(3):282-92. PubMed ID: 1066320
[TBL] [Abstract][Full Text] [Related]
14. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
Karwowska W; Kunicka A
Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor-induced lymphocyte blastogenesis by a factor or factors associated with peripheral leukocytes.
Hattler BG; Soehnlen B
Science; 1974 Jun; 184(4144):1374-5. PubMed ID: 4275320
[TBL] [Abstract][Full Text] [Related]
17. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
[TBL] [Abstract][Full Text] [Related]
19. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets.
Uchida A; Moore M; Klein E
Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
